Lannett: Lannett delisted from New York Stock Exchange
Lannett is below the New York Stock Exchange's continued listing standard that requires companies to maintain an average global market capitalization of at least $15 million.
Read full article »
Lannett is a Pennsylvania-based pharmaceutical company that manufactures and commercializes drugs for the treatment of generic diseases.
Read more